Upper Extremity Deep Vein Thrombosis: A Community-Based Perspective

American Journal of Medicine

Volumn 120, Issue 8, 2007, Pages

  Spencer, Frederick A ^a,b   Emery, Cathy ^a   Lessard, Darleen ^a   Goldberg, Robert J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Deep vein thrombosis; Incidence; Population based; Upper extremity

Indexed keywords

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; POPULATION; PRIORITY JOURNAL; RECURRENCE RISK; STATISTICAL SIGNIFICANCE; UNITED STATES; VENOUS THROMBOEMBOLISM;

AGED; CATHETERIZATION, CENTRAL VENOUS; FEMALE; HUMANS; INCIDENCE; LOWER EXTREMITY; MALE; MASSACHUSETTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; UPPER EXTREMITY; VENOUS THROMBOSIS;

EID: 34547413000     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.06.046     Document Type: Article

References (9)

1. Silverstein M.D., Heit J.A., Mohr D.N., et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population-based study. Arch Intern Med 158 (1998) 585-593
2. Joffe H.V., Kucher N., Tapson V.F., Goldhaber S.Z., and Deep Vein Thrombosis (deep vein thrombosis) FREE Steering Committee. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 110 (2004) 1605-1611
3. Heit J.A., O'Fallon W.M., Petterson T.M., et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162 (2002) 1245-1248
4. Bern M.M., Lokich J.J., Wallach S.R., et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med 112 (1990) 423-428
5. Heaton D.C., Han D.Y., and Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J 32 (2002) 84-88
6. Masci G., Magagnoli M., Zucali P.A., et al. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?. J Clin Oncol 21 (2003) 736-739
7. Monreal M., Alastrue A., Rull M., et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices: prophylaxis with a low-molecular weight heparin (Fragmin). Thromb Haemost 75 (1996) 251-253
8. Buller H.R., Agnelli G., Hull R.D., Hyers T.M., Prins M.H., and Raskob G.E. Antithrombotic therapy for venous thromboembolic disease. Chest 126 (2004) 401S-428S
9. Prandoni P., Polistena P., Bernardi E., et al. Upper-extremity deep vein thrombosis: risk factors, diagnosis, and complications. Arch Intern Med 157 (1997) 57-62